Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis

Rating neurologic impairment in multiple sclerosis

1983 • 14,011 citations

New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

1983 • 7,404 citations

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

1996 • 2,410 citations

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1998 • 2,049 citations

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

1993 • 2,032 citations

Minimization: A new method of assigning patients to treatment and control groups

1974 • 837 citations

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS

1999 • 728 citations

The Clinical Profile of Optic Neuritis

1991 • 559 citations

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up

1998 • 483 citations

THE ROLE OF NMR IMAGING IN THE ASSESSMENT OF MULTIPLE SCLEROSIS AND ISOLATED NEUROLOGICAL LESIONS

1987 • 471 citations

The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis

1993 • 359 citations

Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis

1998 • 334 citations

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis

1998 • 332 citations

The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis

1999 • 286 citations

The 5-year risk of MS after optic neuritis

1997 • 286 citations

Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination

1999 • 142 citations

Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis

1997 • 83 citations